PHIO

#4758
Phio Pharmaceuticals Corp. Common Stock
1.2900 USD
+4.03%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
1.2900
1.2900
Range Annuel
0.9780
1.3500
Changement quotidien
+4.03%
Changement Mensuel
+6.61%
Evolution sur 6 mois
+8.40%
Changement Annuel
+8.40%
Clôture Précédente
1.2400
Open
1.2900
Bid
Ask
Low
1.2900
High
1.2900
Volume
3
Open full chart

Financials

Overview Relevé Statistics
Quarterly Annual
Value 202020212022202320242025 TTM
Key stats
Valuation ratios
Profitability ratios
Liquidity ratios
Solvency ratios
Per share metrics

Phio Pharmaceuticals Corp

Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018.

Nouvelles